+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Childhood Eczema Challenge Grant

National Eczema Association

Nearly 10 million U.S children under the age of 18 are affected by eczema, with one‐third affected by moderate‐to‐severe disease. Despite recent therapeutic advances, the burdens on these patients, and their families, can be significant and many important research questions remain unanswered.

To address this need, the National Eczema Association (NEA) and the Pediatric Dermatology Research Alliance (PeDRA) are collaborating to support targeted clinical research investigations focused on pediatric eczema with the Childhood Eczema Challenge Grant. Through this grant NEA and PeDRA intend to accelerate research that improves the health and quality of life of pediatric eczema patients and their families.

Focus

This Challenge Grant is intended to stimulate early and mid-career scientists as they seek to build and sustain careers as research investigators and future thought leaders within this critical field of study. Research proposals should address at least one of the following priorities related to pediatric eczema:

Eczema Heterogeneity: Novel Insights
Projects aimed at advancing understanding of the underlying factors contributing to the diversity of pediatric eczema clinical presentation, treatment response and comorbidities.
Innovations in Clinical Practice & Care
Studies addressing approaches to facilitate optimal identification and treatment of pediatric eczema and associated comorbidities in all health care settings to enhance patient/caregiver-reported and patient/caregiver-centric outcomes.
Understanding & Alleviating Disease Burden
Insightful proposals that identify, quantify, or aim to reduce aspects of pediatric eczema burden that negatively affect patient or family/caregiver quality of life (including lifestyle, academic, occupational, or economic impacts) based on patient population, treatment approach, etc.
Eczema Prevention
Novel investigations into the potential risk factors and strategies of primary eczema prevention in the pediatric population.

Priority will be given to proposals that focus on clinical or translational research, are broadly applicable, and include a patient-centered or comparative effectiveness framework. Applications that support NEA’s and PeDRA’s commitment to advancing equity, diversity, and inclusion across all facets of their organizations and research are encouraged. Proposals that include basic research will be accepted, however, they should be combined with a significant clinical or translational component. Proposals related to the development or enhancement of mobile apps will not be accepted.

Number of Awards

This is a 1-year non-renewable grant. Awards are contingent on the receipt of sufficiently meritorious applications. Number of awards annually is at NEA and PeDRA’s discretion

Budget

Applicants may request up to $50,000 (USD; direct costs only). Indirect costs are not allowed. Salary and fringe benefit support is allowed. Staff salary support should be commensurate with the percent effort dedicated to the project and explained in budget justification. PI salary support must adhere to the current allowable NIH salary cap.

AI Based Application Success Predictor

1. Strong Alignment with NEA Research Priorities (Strongest Predictor)

NEA funds projects that address its core research priorities, including:

Cutting-edge basic and translational science
Eczema heterogeneity and disease mechanisms
Innovations in clinical care
Disease burden and quality of life
Eczema prevention

Applications clearly linked to these priorities consistently align best with NEA funding objectives.

2. Meaningful Impact for Patients

NEA places substantial emphasis on improving the lives of people living with eczema.

Highly competitive proposals often address:

Itch and symptom burden
Quality of life
Mental health impacts
Long-term disease management
Pediatric outcomes
Patient care improvements

Many funded projects focus directly on outcomes that matter to patients and families.

3. Innovation and Scientific Merit

Successful applications typically demonstrate:

Novel hypotheses
Innovative methodologies
Strong mechanistic insight
Potential to advance eczema science

NEA repeatedly highlights support for "creative scientific ideas" and innovative research approaches.

4. Alignment with the Appropriate Grant Mechanism

NEA offers different grants for different investigator stages:

Engagement Grant – exploratory and pilot projects
Catalyst Grant – early-career investigators building independence
Champion Grant – established investigators addressing major eczema questions
Childhood Eczema Challenge Grant – pediatric eczema research
Spotlight Grant – specific priority topics

Applications that fit the purpose of the chosen mechanism tend to be more successful.

5. Translational Potential

NEA funds both basic and clinical science but strongly values research that may ultimately lead to:

Better therapies
Improved prevention strategies
Enhanced diagnostics
Improved patient management

Projects that bridge laboratory findings and clinical application are often well received.

6. Career Development Potential

For Engagement and Catalyst grants, NEA specifically aims to develop the next generation of eczema researchers.

Successful early-career applicants often demonstrate:

Strong scientific promise
Clear career trajectory
Commitment to eczema research
Potential for research independence

7. Strong Methodology and Feasibility

Competitive applications generally include:

Clear hypotheses
Appropriate study design
Robust statistical plans
Realistic timelines
Feasible recruitment or experimental approaches

Feasibility remains important across all grant categories.

8. Patient-Centered Outcomes Research

NEA has increasingly emphasized research that reflects patient experiences and priorities.

Examples include:

Psychosocial burden
Quality-of-life measures
Treatment experiences
Educational interventions
Long-term disease impacts

Patient-centered outcomes research has been highlighted in recent NEA funding programs.

9. Potential for Follow-On Funding

A notable characteristic of NEA-funded investigators is their ability to obtain larger grants after receiving NEA support.

NEA reports that more than one-third of awardees subsequently received NIH funding, making future funding potential an important implicit success factor.

10. Strong Research Environment

Successful applications often come from institutions with:

Dermatology expertise
Allergy/immunology programs
Translational research infrastructure
Strong mentorship
Access to patient populations

Institutional support increases confidence in successful project completion.

Frequently Funded Research Themes

Recent NEA-funded projects have focused on:

Skin barrier dysfunction
Itch mechanisms
Neuroimmune signaling
Microbiome research
Genetic drivers of eczema
Pediatric eczema
Psychosocial burden
Long-term treatment safety
Disease heterogeneity
Novel therapeutic targets
Prevention strategies
Patient-reported outcomes

Funding Strategy

A highly competitive NEA application typically includes:

A research question directly related to eczema.
Strong alignment with NEA's funding priorities.
Clear patient relevance and potential health impact.
Innovative but feasible methodology.
Strong investigator qualifications relative to career stage.
A realistic path toward improved treatment, prevention, or understanding of eczema.
Potential to generate future external funding and long-term advances in eczema care.

Specialties

Clinical Trials

Dermatology

Eligibility Requirements

Early and mid‐career investigators (Associate Professor level or below and within 15 years of finishing training) are eligible to apply. Applicants need not be trained in pediatric dermatology but must hold the degree of MD and/or PhD (or equivalent) and be eligible to apply for grants under the guidelines of their host institution. Applications may be submitted by either a single investigator or multiple investigators at multiple institutions. Applicants need not be United States citizens and the research need not be conducted in the United States. Applicants may not hold current R‐level funding from NIH (or equivalent) as PI or Co‐PI, however recipients of past or current NEA and/or PeDRA grants are eligible to apply.

Sponsor Details

Sponsor Institute/Organizations: National Eczema Association

Sponsor Type: Corporate/Non-Profit

Address: 505 San Marin Drive, Suite B300, Novato, CA 94945

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity